Skip to menu Skip to content Skip to footer
Associate Professor John O'Sullivan
Associate Professor

John O'Sullivan

Email: 

Overview

Background

After completing neurology training at the Royal Brisbane & Women’s Hospital(RBWH) in 1995, A/Prof O’Sullivan completed Fellowships in Movement Disorders at the Austin & Repatriation Medical Centre, Melbourne then the National Hospital for Neurology and Neurosurgery, and Middlesex Hospital in London, UK. He was awarded a doctorate in Medicine from Melbourne University in 2000 for studies into surgery for Parkinson’s disease. He returned to the RBWH in 2001 and set up the Movement Disorders Clinical Service which he directs including botulinum toxin and later Friedreich's ataxia clinics, and co-ordinating the Huntington's disease multidisciplinary clinic. Through these clinics he has established collaborations with local, interstate and international researchers in the fields of Parkinson's disease, and other movement disorders and neurodegenerative diseases. He is currently Associate Professor of Medicine at UQ Centre for Clinical Research, currently co-director of the Neurodegenertion Clinical Research Group. A/Prof O'Sullivan past President of the Movement Disorders Society of Australia and New Zealand (MDSANZ), having previously served as Chair of the MDSANZ Clinical Trials and Research Group. He has been is on the Council of the Australian and New Zealand Association of Neurolgists (ANZAN) and previously chaired the ANZAN Scientific Program Committee.

Availability

Associate Professor John O'Sullivan is:
Available for supervision
Media expert

Research interests

  • Non-motor features of Parkinson's disease

    This research involves studies into depression, anxiety and cognitive function in Parkinson's disease in collaboration with Dr Nadeeka Dissanayaka, Dr Robert Adam, Prof Gerard Byrne, Dr Nancy Pachana & Dr Rodney Marsh

  • Novel compounds and clinical trials in neurodegenerative diseases

    Research involves novel compounds and repurposed drugs for treatment and disease-modification in Parkinson's, Huntington's disease, Friedreich's Ataxia, Progressive Supranuclear Palsy and motor neurone diseases in collaboration with Dr Richard Gordon, A/Prof Trent Woodruff, A/Prof Rob Henderson, Prof Pam McCombe, Dr Robert Adam and Wesley Medical Research.

  • Exercise in Parkinson's disease

    In collaboration with Prof Sandy Brauer, Dr Robyn Lamont, and Wesley Medical Research, studies exploring maintenance of exercise, gait and boxing in Parkinson's disease.

  • Sleep in neurodegenerative diseases

    These studies in collaboration with Dr Simon Smith, Dr Jane Nikles and Wesley Medical Research explore novel aspects involving sleep in Parkinson's, Huntington's and motor neurone diseases and Friedreich's ataxia

Research impacts

A/Prof O’Sullivan’s novel investigator-initiated clinical trial in Parkinson’s disease (PD) (Mov Dis 2007; 22:1543-9) is cited in the American Academy of Neurology Practice Parameters and MDS Evidence Based Medicine Review of Management of Non-motor symptoms in PD. The initial description of syndrome of Dopamine Dysregulation in PD (JNNP 2000; 68:423-428) complicating dopamine replacement therapy in some patients with Parkinson’s disease has led to widespread recognition of the syndrome, and this paper has had more than 400 citations. The Movement Disorders Society revision of the Unified Parkinson’s Disease Rating Scale (MDS–UPDRS) includes a section to address features of the dopamine dysregulation syndrome as a result of this. This research has also contributed to debate about addiction in general (Addiction. 2012;107(2):253).

Works

Search Professor John O'Sullivan’s works on UQ eSpace

241 works between 1988 and 2025

101 - 120 of 241 works

2015

Journal Article

Characteristics and Treatment of Anxiety Disorders in Parkinson's Disease

Dissanayaka, Nadeeka N. W., White, Elizabeth, O'Sullivan, John D., Marsh, Rodney, Silburn, Peter A., Copland, David A., Mellick, George D. and Byrne, Gerard J. (2015). Characteristics and Treatment of Anxiety Disorders in Parkinson's Disease. Movement Disorders Clinical Practice, 2 (2), 155-162. doi: 10.1002/mdc3.12157

Characteristics and Treatment of Anxiety Disorders in Parkinson's Disease

2015

Conference Publication

Peripheral immune complement activation in neurodegenerative disease

Mantovani, S., Gordon, R., Ngo, S., Pfluger, C., O'Sullivan, J., Noakes, P., Henderson, R., McCombe, P. and Woodruff, T. (2015). Peripheral immune complement activation in neurodegenerative disease. 25th Biennial Meeting of the International-Society-for-Neurochemistry Jointly with the 13th Meeting of the Asian-Pacific-Society-for-Neurochemistry in Conjunction with the 35th Meeting of the Australasian-Neuroscience-Society, Cairns Australia, 23-27 August 2015. Chichester, West Sussex, United Kingdom: Wiley-Blackwell. doi: 10.1111/jnc.13188

Peripheral immune complement activation in neurodegenerative disease

2015

Conference Publication

Cognitive Behaviour Therapy for anxiety in Parkinson’s disease: Outcomes for patients and carers

Pye, D., Dissanayaka, N., Mitchell, L., O'Sullivan, J., Marsh, R., Byrne, G. and Pachana, N. (2015). Cognitive Behaviour Therapy for anxiety in Parkinson’s disease: Outcomes for patients and carers. RANZCP Faculty of Psychiatry of Old Age and APS Psychology and Ageing Special Interest Group Joint Conference, Adelaide, SA Australia, 26-28 November 2015.

Cognitive Behaviour Therapy for anxiety in Parkinson’s disease: Outcomes for patients and carers

2015

Conference Publication

Mindfulness for Parkinson’s disease: a qualitative study

Dissanayaka, N., Idu Jion, F., Harnett, P., O'Sullivan, J. and Pachana, N. (2015). Mindfulness for Parkinson’s disease: a qualitative study. 24th Annual RBWH Health Care Symposium, Brisbane, Australia, 12-16 October 2015.

Mindfulness for Parkinson’s disease: a qualitative study

2015

Conference Publication

Mindfulness to combat anxiety in people with Parkinson’s disease

Dissanayaka, N., Idu Jion, F., Harnett, P., O'Sullivan, J. and Pachana, N. (2015). Mindfulness to combat anxiety in people with Parkinson’s disease. 17th International Psychogeriatric Association International Congress, Berlin, Germany, 13-16 October 2015.

Mindfulness to combat anxiety in people with Parkinson’s disease

2015

Conference Publication

Segmentation Test-Retest of Perfusion Computed Tomography-Obtained Blood-Brain Barrier in Prediction of Infarct Expansion Following Acute Ischaemic Stroke

Shaffer, J., Nguyen, G., Coulthard, A., Wong, A., O'Sullivan, J. and Reutens, D. (2015). Segmentation Test-Retest of Perfusion Computed Tomography-Obtained Blood-Brain Barrier in Prediction of Infarct Expansion Following Acute Ischaemic Stroke. Southern Regional Meeting of the American-Federation-for-Medical-Research, New Orleans, LA, United States, 26-28 February 2015. Philadelphia, United States: Lippincott Williams & Wilkins. doi: 10.1097/JIM.0000000000000146

Segmentation Test-Retest of Perfusion Computed Tomography-Obtained Blood-Brain Barrier in Prediction of Infarct Expansion Following Acute Ischaemic Stroke

2015

Conference Publication

Mindfulness to combat anxiety in people with Parkinson's disease

Pachana, N. A., Dissanayaka, N. N., Jion, F. I., Harnett, P. and O'Sullivan, J. (2015). Mindfulness to combat anxiety in people with Parkinson's disease. Balancing Cure with Care: Advances in Late Life Mental Health, 17th IPA International Congress, Berlin, Germany, 13-16 October 2015. Cambridge, United Kingdom: Cambridge University Press.

Mindfulness to combat anxiety in people with Parkinson's disease

2014

Journal Article

Vertebrobasilar dissections: case series comparing patients with and without dissecting aneurysms

Badve, Monica S., Henderson, Robert D., O'Sullivan, John D., Wong, Andrew A., Mitchell, Ken, Coulthard, Alan and Read, Stephen J. (2014). Vertebrobasilar dissections: case series comparing patients with and without dissecting aneurysms. Journal of Clinical Neuroscience, 21 (11), 2028-2030. doi: 10.1016/j.jocn.2014.02.015

Vertebrobasilar dissections: case series comparing patients with and without dissecting aneurysms

2014

Journal Article

The clinical spectrum of anxiety in Parkinson's disease

Dissanayaka, Nadeeka N. N. W., White, Elizabeth, O'Sullivan, John D., Marsh, Rodney, Pachana, Nancy A. and Byrne, Gerard J. (2014). The clinical spectrum of anxiety in Parkinson's disease. Movement Disorders, 29 (8), 967-975. doi: 10.1002/mds.25937

The clinical spectrum of anxiety in Parkinson's disease

2014

Journal Article

Deep Brain Stimulation for DYT3 Dystonia

Lehn, Alexander, Airey, Caroline, Olson, Sarah, O'Sullivan, John D. and Boyle, Richard (2014). Deep Brain Stimulation for DYT3 Dystonia. Movement Disorders Clinical Practice, 1 (1), 73-75. doi: 10.1002/mdc3.12017

Deep Brain Stimulation for DYT3 Dystonia

2014

Conference Publication

Electrophysiological markers enhancing diagnostic accuracy of depression and cognitive dysfunction in Parkinson’s disease

Dissanayaka, N., Au, T., Angwin, A., O'Sullivan, J., Byrne, G., Silburn, P., Marsh, R., Mellick, G. and Copland, D. (2014). Electrophysiological markers enhancing diagnostic accuracy of depression and cognitive dysfunction in Parkinson’s disease. 23rd Annual RBWH Health Care Symposium, Brisbane, Australia, 13-17 October 2014.

Electrophysiological markers enhancing diagnostic accuracy of depression and cognitive dysfunction in Parkinson’s disease

2014

Conference Publication

Cognitive and Emotional processing in Parkinson’s disease

Dissanayaka, N., Au, T., Angwin, A., O'Sullivan, J., Byrne, G., Silburn, P., Marsh, R., Mellick, G. and Copland, D. (2014). Cognitive and Emotional processing in Parkinson’s disease. 12th International Conference on Cognitive Neurosicence, Brisbane, QLD Australia, 27-31 July 2014.

Cognitive and Emotional processing in Parkinson’s disease

2014

Journal Article

Risk factors for idiopathic dystonia in Queensland, Australia

Newman, Jeremy R. B., Boyle, Richard S., O'Sullivan, John D., Silburn, Peter A. and Mellick, George D. (2014). Risk factors for idiopathic dystonia in Queensland, Australia. Journal of Clinical Neuroscience, 21 (12), 2145-2149. doi: 10.1016/j.jocn.2014.03.032

Risk factors for idiopathic dystonia in Queensland, Australia

2014

Conference Publication

Negative biases and slow negative wave in Parkinson’s disease

Au, T., Angwin, A., Copland, D., O'Sullivan, J., Byrne, G., Silburn, P., Marsh, R., Mellick, G. and Dissanayaka, N. (2014). Negative biases and slow negative wave in Parkinson’s disease. 12th International Conference on Cognitive Neurosicence, Brisbane, QLD Australia, 27-31 July 2014.

Negative biases and slow negative wave in Parkinson’s disease

2014

Conference Publication

Symptomatology and treatment of anxiety in Parkinson’s disease

White, E., Byrne, G., O'Sullivan, J., Marsh, R., Silburn, P., Pachana, N., Mellick, G., Copland, D. and Dissanayaka, N. (2014). Symptomatology and treatment of anxiety in Parkinson’s disease. In: School of Medicine, The University of Queensland Annual Student Symposium, Brisbane, QLD Australia, (). 2014.

Symptomatology and treatment of anxiety in Parkinson’s disease

2013

Journal Article

Genome-wide association study of multiple congenital heart disease phenotypes identifies a susceptibility locus for atrial septal defect at chromosome 4p16

Cordell, Heather J., Bentham, Jamie, Topf, Ana, Zelenika, Diana, Heath, Simon, Mamasoula, Chrysovalanto, Cosgrove, Catherine, Blue, Gillian, Granados-Riveron, Javier, Setchfield, Kerry, Thornborough, Chris, Breckpot, Jeroen, Soemedi, Rachel, Martin, Ruairidh, Rahman, Thahira J., Hall, Darroch, Van Engelen, Klaartje, Moorman, Antoon F.M., Zwinderman, Aelko H., Barnett, Phil, Koopmann, Tamara T., Adriaens, Michiel E., Varro, Andras, George Jr., Alfred L., Dos Remedios, Christobal, Bishopric, Nanette H., Bezzina, Connie R., O'Sullivan, John, Gewillig, Marc ... Keavney, Bernard D. (2013). Genome-wide association study of multiple congenital heart disease phenotypes identifies a susceptibility locus for atrial septal defect at chromosome 4p16. Nature Genetics, 45 (7), 822-824. doi: 10.1038/ng.2637

Genome-wide association study of multiple congenital heart disease phenotypes identifies a susceptibility locus for atrial septal defect at chromosome 4p16

2013

Conference Publication

Deep brain stimulation for DYT3 dystonia: A case report

Lehn, A. C., Airey, C. A., O'Sullivan, J. and Boyle, R. (2013). Deep brain stimulation for DYT3 dystonia: A case report. HOBOKEN: WILEY-BLACKWELL.

Deep brain stimulation for DYT3 dystonia: A case report

2013

Journal Article

'North Sea' progressive myoclonus epilepsy: phenotype of subjects with GOSR2 mutation

Lomax, Lysa Boisse, Bayly, Marta A., Hjalgrim, Helle, Moller, Rikke S., Vlaar, Annemarie M., Aaberg, Kari M., Marquardt, Iris, Gandolfo, Luke C., Willemsen, Michel, Kamsteeg, Erik-Jan, O'Sullivan, John D., Korenke, G. Christoph, Bloem, Bastiaan R., de Coo, Irenaeus F., Verhagen, Judith M. A., Said, Ines, Prescott, Trine, Stray-Pedersen, Asbjorg, Rasmussen, Magnhild, Vears, Danya F., Lehesjoki, Anna-Elina, Corbett, Mark A., Bahlo, Melanie, Gecz, Jozef, Dibbens, Leanne M. and Berkovic, Samuel F. (2013). 'North Sea' progressive myoclonus epilepsy: phenotype of subjects with GOSR2 mutation. Brain, 136 (4), 1146-1154. doi: 10.1093/brain/awt021

'North Sea' progressive myoclonus epilepsy: phenotype of subjects with GOSR2 mutation

2013

Conference Publication

Emotional processing in Parkinson's disease and anxiety: an EEG study of visual affective word processing

Dissanayaka, N., Au, T., Angwin, A., O’Sullivan, J., Byrne, G., Silburn, P., Marsh, R., Mellick, G. and Copland, D. (2013). Emotional processing in Parkinson's disease and anxiety: an EEG study of visual affective word processing. BaCI 2013: First International Conference on Basic and Clinical Multimodal Imaging, Geneva, Switzerland, 5-8 September, 2013. Thousand Oaks, CA, United States: Sage Publications. doi: 10.1177/1550059413507209

Emotional processing in Parkinson's disease and anxiety: an EEG study of visual affective word processing

2013

Conference Publication

Patient perspectives on treatment-induced impulse control disorders

Carter, Adrian, Bell, Peter, Diezel, Helene, Dissanayaka, Nadeeka, O'Sullivan, John and Hall, Wayne (2013). Patient perspectives on treatment-induced impulse control disorders. Australasian Professional Society on Alcohol and other Drugs Conference, Brisbane, QLD Australia, 24-27 November 2013. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing Ltd.. doi: 10.1111/dar.12077

Patient perspectives on treatment-induced impulse control disorders

Funding

Current funding

  • 2024 - 2028
    A randomised controlled trial, of N-Acetyl Cysteine, for premanifest Huntingtin gene expansion carriers (NAC-preHD)
    Western Sydney Local Health District
    Open grant
  • 2023 - 2026
    A randomised controlled trial of N-Acetyl Cysteine for premanifest Huntington gene expansion carriers (NAC-preHD)
    Huntington's Australia Research Grant
    Open grant
  • 2023 - 2026
    Mining the gut microbiome to develop new treatments and biomarkers for Parkinson's disease
    Wesley Medical Research Ltd
    Open grant
  • 2023 - 2027
    Enhancing utility of neuropsychological evaluation for earlier and effective diagnosis of dementia in Parkinson's disease
    NHMRC MRFF Dementia, Ageing and Aged Care Mission
    Open grant
  • 2022 - 2025
    Mining the inflammasome-gut microbiome axis to uncover new biomarkers and therapeutic targets for Parkinson's disease
    Research Donation Generic
    Open grant
  • 2022 - 2025
    Validating Magnetic Resonance diagnosis in Parkinson's Disease
    Research Donation Generic
    Open grant
  • 2022 - 2026
    Gilchrist Family Parkinson's Research Program
    Research Donation Generic
    Open grant
  • 2020 - 2025
    Sodium Selenate as a Disease Modifying Treatment for Progressive Supranuclear Palsy (Sodium Selenate for PSP) (MRFF RCRDUN Neurological Disorders Grant administered by Monash University)
    Monash University
    Open grant

Past funding

  • 2024 - 2025
    Evaluation of noval disease-modifying therapeutics for Parkinson's disease (The Michael J. Fox Foundation for Parkinson's Research Project led by QUT)
    Queensland University of Technology
    Open grant
  • 2022 - 2024
    Evaluation of Tolebrutinib as a novel disease-modifying therapeutic for Parkinson's disease
    The Michael J Fox Foundation Therapeutic Pipeline Program
    Open grant
  • 2021 - 2023
    Comparative and Cross Validation of alpha- Synuclein Seeding Assays in Peripheral Biomatrices skin, submandibular gland, CSF, Saliva and Tear Fluids
    University of Georgia
    Open grant
  • 2021 - 2023
    Validating the functional role of the pathogenic microbiome metabolite Trimethylamine (TMA) at the gut-brain axis in Parkinson's disease
    The Michael J Fox Foundation for Parkinsons Research
    Open grant
  • 2021 - 2022
    Uncovering a novel therapeutic target to reduce dementia risk in Parkinson's disease
    Metro North Hospital and Health Service
    Open grant
  • 2021 - 2022
    Uncovering a novel therapeutic target to reduce dementia risk in Parkinson's disease (TRIP study)
    Metro North Hospital and Health Service
    Open grant
  • 2019 - 2022
    A randomised placebo-controlled crossover trial of micronised resveratrol as a treatment for Friedreich ataxia
    Murdoch Childrens Research Institute
    Open grant
  • 2019 - 2022
    Pharmacological targeting of inflammasome activation mechanisms in synuclein models of Parkinson's disease
    The Michael J Fox Foundation for Parkinsons Research
    Open grant
  • 2018 - 2019
    Targeting peripheral inflammatory pathology in Parkinson's disease using repurposed drugs
    Wesley Medical Research Ltd
    Open grant
  • 2018 - 2023
    A randomised controlled trial, of N-Acetyl Cysteine, for premanifest Huntingtin gene expansion carriers (NAC-preHD) (MRFF LCTRC administered by University of Sydney)
    University of Sydney
    Open grant
  • 2018
    Sleep measurements in Friedreich's ataxia, Huntington's disease patients and healthy volunteers
    Wesley Medical Research Ltd
    Open grant
  • 2018 - 2019
    Virtual reality innovation to treat anxiety in patients with cognitive impairment and Parkinson's Disease
    Metro North Hospital and Health Service
    Open grant
  • 2017 - 2019
    Therapeutic switching of a licensed oncology drug to target neuropathology in Parkinson's disease
    The Cure Parkinson's Trust
    Open grant
  • 2017 - 2019
    Defining inflammatory biomarkers in motor neuron disease patients to assist in clinical trial efficiency of the C5aR antagonist PMX205
    Wesley Medical Research Ltd
    Open grant
  • 2017 - 2023
    The Queensland Drug Repurposing Initiative
    Queensland Government Advance Queensland Innovation Partnerships
    Open grant
  • 2016 - 2018
    Pharmacological Targeting of Proinflammatory Kinase Signalling in Parkinson's disease
    The Michael J Fox Foundation for Parkinsons Research
    Open grant
  • 2016 - 2017
    Cognitive behaviour therapy for anxiety in Parkinson's disease: outcomes for patients and caregivers
    Royal Brisbane and Women's Hospital Foundation
    Open grant
  • 2015 - 2017
    Complement activation as a therapeutic target and clinical biomarker for Parkinson's disease
    NHMRC Project Grant
    Open grant
  • 2015 - 2016
    Mindfulness therapy for depression, anxiety, motor and cognitive dysfunction in Parkinson's disease
    Royal Brisbane and Women's Hospital
    Open grant
  • 2014 - 2016
    Developing a non-invasive composite measure to enhance accuracy of identifying anxiety in Parkinson's disease
    Royal Brisbane and Women's Hospital
    Open grant
  • 2013 - 2014
    Characterising anxiety in Parkinson's disease: A psycholinguistic and psychophysiology study comparing to anxious older adults
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2012 - 2013
    Improving diagnostic methods of anxiety disorders in Parkinson's disease: Phase 2
    Royal Brisbane & Women's Hospital Research Foundation
    Open grant
  • 2011 - 2013
    Therapeutic Targeting of Complement C5a Receptors in Huntington's Disease
    NHMRC Project Grant
    Open grant

Supervision

Availability

Associate Professor John O'Sullivan is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    The evolution of cognitive deficits in Lewy body disorders and related degenerative diseases.

    Associate Advisor

    Other advisors: Professor Peter Nestor

  • Master Philosophy

    Digital symptom tracking - using digital tools for measuring and tracking motor, cognitive, and speech changes

    Associate Advisor

Completed supervision

Media

Enquiries

Contact Associate Professor John O'Sullivan directly for media enquiries about:

  • Botulinum toxin
  • Dystonia
  • Huntington's disease
  • Movement disorders
  • Parkinson's disease

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au